Voyager Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Voyager Therapeutics Inc
TickerVYGR
CIK #0001640266
CUSIP92915B106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address75 Sidney Street, Cambridge, MA 02139
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Voyager Therapeutics Inc 2024-01-17 20.0 M Exemption: 506(b) · Duration: One year or less · Commission: $400,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001640266] 10-K
[0001640266] 10-Q
[0001640266] 3
[0001640266] 4
[0001640266] 8-K
[0001640266] D
[0001640266] SC 13D
[0001640266] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Integrated Core Strategies US LLC Voyager Therapeutics Inc [2026-01-26] 0.0
BlackRock Inc Voyager Therapeutics Inc [2024-01-29] 6.0
Armistice Capital LLC Voyager Therapeutics Inc [2023-02-14] 8.8
EcoR1 Capital LLC Voyager Therapeutics Inc [2021-10-22] 0.4
Armistice Capital LLC Voyager Therapeutics Inc [2020-03-05] 5.4
Vanguard Group Inc Voyager Therapeutics Inc [2020-02-11] 5.64
Partner Fund Management LP Voyager Therapeutics Inc [2019-04-01] 6.0
Neurocrine Biosciences Inc Voyager Therapeutics Inc [2019-03-14] 12.8
UBS Group AG Voyager Therapeutics Inc [2019-02-15] 6.1
BlackRock Inc Voyager Therapeutics Inc [2019-02-08] 5.7
Armistice Capital LLC Voyager Therapeutics Inc [2018-09-21] 5.3
BB Biotech AG Voyager Therapeutics Inc [2018-01-10] 5.6
Voyager Therapeutics Inc MRI Interventions Inc [2016-09-12] 21.04
Sanofi Voyager Therapeutics Inc [2016-02-12] 0.3
Wellington Management Group LLP Voyager Therapeutics Inc [2016-02-11] 5.5
Wellington Management Group LLP Voyager Therapeutics Inc [2016-02-11] 5.5
Third Rock Ventures III LP Voyager Therapeutics Inc [2016-02-10] 41.4
FMR LLC Voyager Therapeutics Inc [2015-12-10] 0.0
Partner Fund Management LP Voyager Therapeutics Inc [2015-11-20] 3.3
Brookside Capital Partners Fund LP Voyager Therapeutics Inc [2015-11-18] 4.52
Flynn James E Voyager Therapeutics Inc [2015-11-12] 3.36
Form 3/4/5 Filer 2011 - 2026
Voyager Therapeutics Inc
Colon Grace
Mackey Catherine J
Hyman Steven
Vitale Nancy
Higgins Michael J
Onyia Jude
Pierce Glenn
Geraghty James A
Scangos George A
Quinlan Amy
Sandrock Alfred
Shiferman Gregory L
Carter Todd Alfred
Jorgensen Nathan D
Swartz Robin
Ferguson Toby
Fahey Sandell Jacquelyn
Pfreundschuh Peter P
Hesslein Robert W
Neurocrine Biosciences Inc
Third Rock Ventures III LP
Third Rock Ventures GP III LP
TRV GP III LLC
Tepper Robert I
EcoR1 Capital LLC
Burek Julie
Paul Steven M
Levin Mark J
Khwaja Omar
Turenne Andre
Dorval Allison
Dixon Wendy L
Ottmer Matthew P
Karsen Perry A
Sah Dinah PhD
Starr Kevin P
Ravina Bernard
Henderson Jane
MRI Interventions Inc
Goater Jeff
Hadley Harbor Master Investors Cayman LP
Sanofi
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Sandrock Alfred
Common Stock
2026-02-24 Sell 14,197 $3.79 53,807
Carter Todd Alfred
Common Stock
2026-02-24 Sell 4,174 $3.76 15,694
Jorgensen Nathan D
Common Stock
2026-02-24 Sell 4,668 $3.77 17,598
Swartz Robin
Common Stock
2026-02-24 Sell 6,458 $3.77 24,347
Sandrock Alfred
Common Stock
2026-02-18 Sell 11,732 $3.41 40,006
Swartz Robin
Common Stock
2026-02-18 Sell 3,882 $3.44 13,354
Carter Todd Alfred
Common Stock
2026-02-18 Sell 3,301 $3.44 11,355
Swartz Robin
Common Stock
2026-02-10 Sell 4,569 $3.85 17,591
Sandrock Alfred
Common Stock
2026-02-10 Sell 12,192 $3.78 46,086
Carter Todd Alfred
Common Stock
2026-02-10 Sell 3,525 $3.85 13,571
Swartz Robin
Stock Option (Right to Buy) · derivative
2026-02-06 Grant 210,000 $0.00
Ferguson Toby
Common Stock
2026-02-06 Grant 45,000 $0.00
Carter Todd Alfred
Common Stock
2026-02-06 Grant 33,000 $0.00
Swartz Robin
Common Stock
2026-02-06 Grant 45,000 $0.00
Sandrock Alfred
Common Stock
2026-02-06 Grant 86,250 $0.00
Jorgensen Nathan D
Common Stock
2026-02-06 Grant 32,250 $0.00
Ferguson Toby
Stock Option (Right to Buy) · derivative
2026-02-06 Grant 210,000 $0.00
Carter Todd Alfred
Stock Option (Right to Buy) · derivative
2026-02-06 Grant 154,000 $0.00
Sandrock Alfred
Stock Option (Right to Buy) · derivative
2026-02-06 Grant 402,500 $0.00
Jorgensen Nathan D
Stock Option (Right to Buy) · derivative
2026-02-06 Grant 150,500 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 135 33,720,629
2025-12-31 125 33,895,115
2025-09-30 117 30,451,667
2025-06-30 113 33,430,977
2025-03-31 117 34,702,516
2024-12-31 134 34,586,643
2024-09-30 129 35,386,899
2024-06-30 128 37,454,961
2024-03-31 133 35,021,929
2023-12-31 109 26,253,837
2023-09-30 112 25,554,713
2023-06-30 107 25,023,181
Form 13F Holdings
Firm Period DFND Voting Shares
Patriot Financial Group Insurance Agency LLC [2026-06-30] SOLE 96,050 96,050
Diversified Trust Co [2026-06-30] SOLE 0 20,468
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 451 16,052
HM Payson & Co [2026-06-30] SOLE 500 500
True Wealth Design LLC [2026-06-30] SOLE 0 491
Toth Financial Advisory Corp [2026-06-30] SOLE 0 250
Gamma Investing LLC [2026-06-30] DFND 172 172
IFP Advisors LLC [2026-06-30] SOLE 93 93
Hunter Perkins Capital Management LLC [2026-06-30] SOLE 0 20
Farther Finance Advisors LLC [2026-06-30] SOLE 0 14
Ritter Daniher Financial Advisory LLC / DE [2026-06-30] SOLE 0 5
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com